Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Gets Price Target Trim from Needham & Company LLC
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price reduced by Needham & Company LLC from $357.00 to $243.00 in a report released on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the company. Zacks Research lowered Alnylam […]
1 Nov 05:42 · The Markets Daily